Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

News Features

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

Shelley Wood

December 30, 2016

News Conference News TCT 2016

COLOR: PCI of Lipid-Rich Plaque Not Associated With Increased Risk of Adverse Events

Michael O'Riordan

November 01, 2016

News Daily News

AHA Provides Guidance on Drug-Drug Interactions With Statins and CVD Medications

Michael O'Riordan

October 18, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2016

Shelley Wood

September 30, 2016

News Daily News

TCTMD’s Top 10 Most Popular Stories for September 2016

Shelley Wood

September 30, 2016

News Daily News

Underuse of Medical Therapy Linked With Increased Adverse Events in Very Elderly

Michael O'Riordan

July 21, 2016

News Daily News

Statins Tied to Lower Mortality, Amputation Risks in PAD

Michael O'Riordan

May 09, 2016

News Daily News

NSTE-ACS Patients With Inflammation Gain the Most Kidney Protection From Statin Pretreatment

Yael L. Maxwell

December 15, 2014

News Daily News

Statins More Beneficial Before PCI Than After in ACS Patients

March 13, 2014

News Daily News

La Atorvastatina Potencia la Eficacia del Clopidogrel en Pacintes con Alta Reactividad Plaquetaria

February 25, 2013

News Daily News

Atorvastatin Boosts Clopidogrel Efficacy in Patients with High Platelet Reactivity

February 25, 2013

News Daily News

Risk Factor Control Linked to Better Outcomes After Peripheral Intervention

Caitlin E. Cox

December 16, 2012

News Daily News

El Control del Factor de Riesgo se asocia a Mejores Resultados tras una Intervención Periférica

Caitlin E. Cox

December 16, 2012

News Daily News

Switching to Non-CYP3A4-Metabolized Statins May Reduce High Platelet Reactivity

April 25, 2012

News Daily News

Cambiar a Estatinas No Metabolizadas por CYP3A4 podría Reducir la Alta Reactividad Plaquetaria

April 25, 2012

Advertisement

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

COLOR: PCI of Lipid-Rich Plaque Not Associated With Increased Risk of Adverse Events

AHA Provides Guidance on Drug-Drug Interactions With Statins and CVD Medications

TCTMD’s Top 10 Most Popular Stories for September 2016

TCTMD’s Top 10 Most Popular Stories for September 2016

Underuse of Medical Therapy Linked With Increased Adverse Events in Very Elderly

Statins Tied to Lower Mortality, Amputation Risks in PAD

NSTE-ACS Patients With Inflammation Gain the Most Kidney Protection From Statin Pretreatment

Statins More Beneficial Before PCI Than After in ACS Patients

La Atorvastatina Potencia la Eficacia del Clopidogrel en Pacintes con Alta Reactividad Plaquetaria

Atorvastatin Boosts Clopidogrel Efficacy in Patients with High Platelet Reactivity

Risk Factor Control Linked to Better Outcomes After Peripheral Intervention

El Control del Factor de Riesgo se asocia a Mejores Resultados tras una Intervención Periférica

Switching to Non-CYP3A4-Metabolized Statins May Reduce High Platelet Reactivity

Cambiar a Estatinas No Metabolizadas por CYP3A4 podría Reducir la Alta Reactividad Plaquetaria

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content